Teneligliptin Hydrobromide Hydrate is used as an oral antidiabetic medication for managing type 2 diabetes mellitus. It works by inhibiting the DPP-4 enzyme, which increases levels of incretin hormones, enhancing insulin secretion and suppressing glucagon release. This helps in lowering blood glucose levels, especially after meals. It is often used alone or in combination with other antidiabetic drugs like metformin. It is grouped under the following drug class(es): DPP-4 inhibitors and Hypoglycemics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Tenelia and Teneligliptin HBr Hydrate. Its PubChem CID is 53297474.
Teneligliptin hydrobromide hydrate
| CAS No | 1572583-29-9 |
|---|---|
| Molecular Formula | C44H67Br5N12O3S2 |
| Molecular Weight | 1275.7 g/mol |
| Synonyms | [(2S,4S)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone;hydrate;pentahydrobromide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Teneligliptin Hydrobromide Hydrate is used as an oral antidiabetic medication for managing type 2 diabetes mellitus. It works by inhibiting the DPP-4 enzyme, which increases levels of incretin hormones, enhancing insulin secretion and suppressing glucagon release.
The listed CAS number is 1572583-29-9.
The listed molecular formula is C44H67Br5N12O3S2.
The listed molecular weight is 1275.7 g/mol.
[(2S,4S)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone;hydrate;pentahydrobromide.
The source lists Tenelia and Teneligliptin HBr Hydrate.